Overview
Salaries
Products
People
Growth
Offices
Financials

Investor profile

Venture capital
Investments
41
18 of them startups
Hiring now
10
89 open roles
Rounds in 12 months
4
$332.4M raised
Exits
6
Focusshare of its companies
Drug Discovery 10%Prescription Drugs 10%Immunology & Inflammation Therapeutics 7%Cell & Gene Therapy 5%Rare Disease Therapeutics 5%Cardiometabolic Therapeutics 5%Biologics & Biosimilars 5%Respiratory & Sleep Devices 2%
Where its companies are
United States 17%United Kingdom 5%
Stage of its companies
Venture, series not stated 50%Series B 25%Series A 17%Series C and later 8%

Overview

SR One is a venture capital firm investing in biotechnology and life sciences companies developing transformative medicines. It backs companies from early to late stage across therapeutic modalities, working with founders in the United States and Europe to build and scale drug development businesses. Originally established in 1985 as the corporate venture arm of GSK, SR One became an independent firm in 2020 and is based in Philadelphia with offices in the San Francisco Bay Area and London.

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Philadelphia United States
HQ